GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 226 filers reported holding GENOMIC HEALTH INC in Q4 2018. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,168,000 | +121.6% | 16,678 | +103.9% | 0.07% | +105.9% |
| Q4 2018 | $527,000 | -67.2% | 8,178 | -74.3% | 0.03% | -47.7% |
| Q2 2018 | $1,606,000 | +53.4% | 31,871 | -4.8% | 0.06% | +54.8% |
| Q1 2018 | $1,047,000 | +280.7% | 33,493 | +295.1% | 0.04% | +180.0% |
| Q2 2017 | $275,000 | +32.9% | 8,478 | +28.9% | 0.02% | +50.0% |
| Q1 2017 | $207,000 | -68.4% | 6,578 | -70.5% | 0.01% | -74.4% |
| Q4 2016 | $655,000 | +70.1% | 22,300 | +43.1% | 0.04% | +129.4% |
| Q1 2016 | $385,000 | -75.3% | 15,580 | -64.8% | 0.02% | -77.0% |
| Q4 2015 | $1,558,000 | +385.4% | 44,280 | +262.5% | 0.07% | +335.3% |
| Q1 2014 | $321,000 | -51.4% | 12,215 | -45.9% | 0.02% | -51.4% |
| Q4 2013 | $660,000 | +117.1% | 22,579 | +126.6% | 0.04% | +105.9% |
| Q3 2013 | $304,000 | – | 9,963 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,668,866 | $353,955,000 | 3.71% |
| Camber Capital Management LP | 2,458,100 | $63,652,000 | 3.08% |
| Ghost Tree Capital, LLC | 200,000 | $5,179,000 | 1.50% |
| Tributary Capital Management, LLC | 206,291 | $5,342,000 | 0.78% |
| Motley Fool Asset Management LLC | 131,935 | $3,416,000 | 0.74% |
| CORRADO ADVISORS, LLC | 40,695 | $1,054,000 | 0.68% |
| Broadfin Capital, LLC | 270,400 | $7,002,000 | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 48,800 | $1,264,000 | 0.61% |
| Motley Fool Wealth Management, LLC | 123,018 | $3,186,000 | 0.35% |
| TFS CAPITAL LLC | 61,773 | $1,600,000 | 0.29% |